Drucker Wealth 3.0 LLC bought a new position in CME Group Inc. (NASDAQ:CME - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 2,191 shares of the financial services provider's stock, valued at approximately $604,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of CME Group by 1.2% in the first quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider's stock worth $9,190,661,000 after buying an additional 400,737 shares during the period. Raymond James Financial Inc. boosted its holdings in shares of CME Group by 9.7% during the first quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider's stock worth $1,091,401,000 after purchasing an additional 363,130 shares during the period. Vontobel Holding Ltd. boosted its holdings in shares of CME Group by 3.0% during the second quarter. Vontobel Holding Ltd. now owns 2,920,046 shares of the financial services provider's stock worth $804,823,000 after purchasing an additional 84,005 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in shares of CME Group by 29.9% during the first quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider's stock worth $747,744,000 after purchasing an additional 648,591 shares during the period. Finally, AQR Capital Management LLC boosted its holdings in shares of CME Group by 10.3% during the first quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider's stock worth $735,539,000 after purchasing an additional 260,065 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, General Counsel Jonathan L. Marcus sold 392 shares of the business's stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel owned 7,851 shares of the company's stock, valued at approximately $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the business's stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 over the last three months. Corporate insiders own 0.30% of the company's stock.
Analyst Ratings Changes
Several analysts recently commented on CME shares. Jefferies Financial Group decreased their price target on shares of CME Group from $313.00 to $304.00 and set a "buy" rating for the company in a report on Friday. Deutsche Bank Aktiengesellschaft decreased their price target on shares of CME Group from $276.00 to $266.00 and set a "hold" rating for the company in a report on Thursday. UBS Group decreased their price target on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a report on Monday, September 8th. Barclays reduced their target price on shares of CME Group from $298.00 to $280.00 and set an "equal weight" rating for the company in a research note on Wednesday. Finally, JPMorgan Chase & Co. raised their price target on shares of CME Group from $246.00 to $252.00 and gave the company an "underweight" rating in a report on Thursday, September 25th. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $281.00.
Read Our Latest Report on CME
CME Group Price Performance
Shares of CME Group stock opened at $271.45 on Friday. The firm has a fifty day simple moving average of $268.89 and a 200-day simple moving average of $271.22. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79. The stock has a market capitalization of $97.83 billion, a price-to-earnings ratio of 26.28, a PEG ratio of 5.72 and a beta of 0.41.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same period in the previous year, the company earned $2.56 earnings per share. CME Group's revenue for the quarter was up 10.4% on a year-over-year basis. On average, sell-side analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Tuesday, September 9th. CME Group's payout ratio is presently 48.40%.
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report